Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

被引：9

作者：

Huebl, Kai ^{[1
]}

Re, Alessandro ^{[2
]}

Boumendil, Ariane ^{[3
]}

Finel, Herve ^{[4
]}

Hentrich, Marcus ^{[5
]}

Robinson, Stephen ^{[6
]}

Wyen, Christoph ^{[7
]}

Michieli, Mariagrazia ^{[8
]}

Kanfer, Edward ^{[9
]}

Diez-Martin, Jose Luis ^{[10
]}

Balsalobre, Pascual ^{[10
]}

Vincent, Laure ^{[11
]}

Schroyens, Wilfried ^{[12
]}

Ribera Santasusana, Josep Maria ^{[13
]}

Kroeger, Nicolaus ^{[14
]}

Schiel, Xaver ^{[15
]}

Cwynarski, Kate ^{[16
]}

Esquirol, Albert ^{[17
]}

Sousa, Aida Botelho ^{[18
]}

Cattaneo, Chiara ^{[2
]}

Montoto, Silvia ^{[19
]}

Dreger, Peter ^{[20
]}

机构：

[1] Univ Hosp Cologne, Cologne, Germany

[2] Spedali Civili Brescia, Hematol, Brescia, Italy

[3] CEREST TC, EBMT Paris Study Off, Paris, France

[4] Hop St Antoine, EBMT Paris Study Off, Paris, France

[5] Rotkreuzklinikum Munchen, Munich, Germany

[6] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England

[7] Praxis Ebertpl, Cologne, Germany

[8] Ctr Riferimento Oncol, Aviano, Italy

[9] Hammersmith Hosp London, London, England

[10] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[11] Hosp Ctr Univ, Montpellier, France

[12] Univ Hosp Antwerpen, Antwerp, Belgium

[13] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

[14] Univ Hosp Eppendorf, Hamburg, Germany

[15] Klinikum Harlaching, Munich, Germany

[16] Univ Coll Hosp, London, England

[17] Hosp Santa Creu & Santpau, Barcelona, Spain

[18] Hosp Capuchos, Lisbon, Portugal

[19] Barts Hlth NHS Trust, St Bartholomews Hosp, London, England

[20] Univ Hosp Heidelberg, Heidelberg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷 / 10期

关键词：

HIGH-DOSE THERAPY; CLINICAL-PRACTICE GUIDELINES; NON-HODGKIN-LYMPHOMA; PLASMABLASTIC LYMPHOMA; IMMUNODEFICIENCY; RISK; DIAGNOSIS; SURVIVAL; BLOOD;

D O I：

10.1038/s41409-019-0480-x

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

The present study aimed at describing the outcome of patients with HIV-associated lymphomas following autologous hematopoietic stem cell transplantation (autoHCT) in the rituximab and combined antiretroviral therapy (cART) era. Eligible for this retrospective study were HIV-positive patients with lymphoma who received autoHCT between 2007 and 2013. A total of 118 patients were included with a median age of 45 years (range 24-66). Underlying diagnoses were diffuse large B cell lymphoma in 47%, Hodgkin lymphoma in 24%, Burkitt lymphoma in 18%, and plasmablastic lymphoma in 7% of patients. Disease status at autoHCT was complete remission in 44%, partial remission (PR) in 38%, and less than PR in 18% of the patients. With a median follow-up of 4 years, 3-year non-relapse mortality, incidence of relapse, progression-free survival (PFS) and overall survival (OS) were 10%, 27%, 63% and 66%, respectively. By multivariate analysis, disease status less than PR but not CD4+ cell count at the time of autoHCT was a significant predictor of unfavorable PFS and OS. In conclusion, in the era of cART and chemoimmunotherapy, the outcome of autoHCT for HIV-related lymphoma is driven by lymphoma-dependent risk factors rather than by characteristics of the HIV infection.

引用

页码：1625 / 1631

页数：7

共 50 条

[21] Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT
Domingo-Domenech, E.
Boumendil, A.
Climent, F.
Sengeloev, H.
Wahlin, B.
Wattad, W.
Arat, M.
Finel, H.
Schapp, N.
Ganser, A.
Yeshurun, M.
Pavone, V.
Snowden, J.
Finke, J.
Montoto, S.
Sureda, A.
Dreger, P.
BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 796 - 803
[22] Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT
E. Domingo-Domènech
A. Boumendil
F. Climent
H. Sengeloev
B. Wahlin
W. Wattad
M. Arat
H. Finel
N. Schapp
A. Ganser
M. Yeshurun
V. Pavone
J. Snowden
J. Finke
S. Montoto
A. Sureda
P. Dreger
Bone Marrow Transplantation, 2020, 55 : 796 - 803
[23] Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT
Jantunen, Esa
Boumendil, Ariane
Finel, Herve
Luan, Jian-Jian
Johnson, Peter
Rambaldi, Alessandro
Haynes, Andrew
Duchosal, Michel A.
Bethge, Wolfgang
Biron, Pierre
Carlson, Kristina
Craddock, Charles
Rudin, Claudius
Finke, Jurgen
Salles, Gilles
Kroschinsky, Frank
Sureda, Anna
Dreger, Peter
BLOOD, 2013, 121 (13) : 2529 - 2532
[24] Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT
Rubio, Marie T.
Boumendil, Ariane
Luan, Jian Jian
Canals, Carmen
Lefrere, Francois
Attal, Michel
Ferrant, Augustin
Buzyn, Agnes
Rio, Bernard
Schattenberg, Anton
Llamas, Juan Carlos Vallejo
Tilly, Herve
Biron, Pierre
Milpied, Noel-Jean
Blaise, Didier
Jouet, Jean-Pierre
Crawley, Charles
Dreger, Peter
Sureda, Anna
Hermine, Olivier
BLOOD, 2010, 116 (21) : 303 - 303
[25] Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party—EBMT
Leyre Bento
Ariane Boumendil
Hervé Finel
Irma Khvedelidze
Didier Blaise
Nathalie Fegueux
Luca Castagna
Edouard Forcade
Patrice Chevallier
Nicola Mordini
Pauline Brice
Eric Deconinck
Martin Gramatzki
Paolo Corradini
Mathilde Hunault
Maurizio Musso
Anna Tsoulkani
Dolores Caballero
Sandro Nati
Silvia Montoto
Anna Sureda
Bone Marrow Transplantation, 2021, 56 : 655 - 663
[26] Haematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a retrospective survey of the Lymphoma Working Party of the EBMT
Siegloch, K.
Schmitz, N.
Friedrichs, B.
Hamilton, E.
van Imhoff, G. W.
Montoto, S.
Luan, J.
Ribera, J. M.
Delage, R.
Sureda, A.
BONE MARROW TRANSPLANTATION, 2010, 45 : S250 - S250
[27] Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party
S P Robinson
A Boumendil
H Finel
D Blaise
X Poiré
E Nicolas-Virelizier
R Or
R Malladi
A Corby
L Fornecker
D Caballero
D Pohlreich
A Nagler
C Thieblemont
J Finke
E Bachy
L Vincent
W Schroyens
H Schouten
P Dreger
Bone Marrow Transplantation, 2016, 51 : 365 - 371
[28] Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party
Robinson, S. P.
Boumendil, A.
Finel, H.
Blaise, D.
Poire, X.
Nicolas-Virelizier, E.
Or, R.
Malladi, R.
Corby, A.
Fornecker, L.
Caballero, D.
Pohlreich, D.
Nagler, A.
Thieblemont, C.
Finke, J.
Bachy, E.
Vincent, L.
Schroyens, W.
Schouten, H.
Dreger, P.
BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 365 - 371
[29] Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT
Bento, Leyre
Boumendil, Ariane
Finel, Herve
Khvedelidze, Irma
Blaise, Didier
Fegueux, Nathalie
Castagna, Luca
Forcade, Edouard
Chevallier, Patrice
Mordini, Nicola
Brice, Pauline
Deconinck, Eric
Gramatzki, Martin
Corradini, Paolo
Hunault, Mathilde
Musso, Maurizio
Tsoulkani, Anna
Caballero, Dolores
Nati, Sandro
Montoto, Silvia
Sureda, Anna
BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 655 - 663
[30] Autologous stem cell transplantation in HIV-related lymphoma in the rituximab era - a feasibility study in a monocentric cohort
Wieters, Imke
Atta, Johannes
Kann, Gerrit
Owasil, Junaid
Goepel, Siri
Haberl, Annette
Stephan, Christoph
Wolf, Timo
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 102 - 103

← 1 2 3 4 5 →